Catalyst Wire Dossier Catalyst Wire Dossier

autogenic NK immunotherapy

· Fuda Cancer Hospital, Guangzhou
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for autogenic NK immunotherapy, covering 2019-09-12 to 2019-09-12. Get the full timeline:

Most recent: Clinical Trial Update: Comparison of Autogenic and Allogenic NK Immunotherapy on the Outcome of Recurrent Solid Tumors [Phase 2]

See pricing